Cargando…
Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
Chronic kidney disease is associated with increased risk of CKD progression and death. Therapeutic approaches to limit progression are limited. Developing tools for the early identification of those individuals most likely to progress will allow enriching clinical trials in high risk early CKD patie...
Autores principales: | Rodríguez-Ortiz, María E., Pontillo, Claudia, Rodríguez, Mariano, Zürbig, Petra, Mischak, Harald, Ortiz, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206033/ https://www.ncbi.nlm.nih.gov/pubmed/30374033 http://dx.doi.org/10.1038/s41598-018-34386-8 |
Ejemplares similares
-
Publisher Correction: Novel Urinary Biomarkers For Improved Prediction Of Progressive eGFR Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease
por: Rodríguez-Ortiz, María E., et al.
Publicado: (2018) -
Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease
por: Pontillo, Claudia, et al.
Publicado: (2017) -
Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes
por: Magalhães, Pedro, et al.
Publicado: (2020) -
Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria
por: Øvrehus, Marius A, et al.
Publicado: (2015) -
Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)